US Stock MarketDetailed Quotes

Orchestra BioMed (OBIO)

Watchlist
  • 4.062
  • +0.002+0.04%
Trading May 14 10:15 ET
243.21MMarket Cap-4.28P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Orchestra BioMed (OBIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-87.33%110K
1,169.22%33.48M
12,120.16%30.92M
-12.77%861K
7.46%836K
40.00%868K
-4.42%2.64M
-3.44%253K
135.56%987K
-14.97%778K
Operating revenue
-87.33%110K
1,169.22%33.48M
12,120.16%30.92M
-12.77%861K
7.46%836K
40.00%868K
-4.42%2.64M
-3.44%253K
135.56%987K
-14.97%778K
Cost of revenue
-27.27%32K
-6.86%190K
-12.07%51K
-27.94%49K
4.55%46K
29.41%44K
9.68%204K
23.40%58K
65.85%68K
-18.52%44K
Gross profit
-90.53%78K
1,267.79%33.29M
15,728.72%30.87M
-11.64%812K
7.63%790K
40.61%824K
-5.44%2.43M
-9.30%195K
143.12%919K
-14.75%734K
Operating expense
12.20%22.15M
27.52%85.1M
42.91%24.11M
22.39%21.13M
14.35%20.12M
31.55%19.75M
23.40%66.74M
32.89%16.87M
15.83%17.26M
27.33%17.59M
Selling and administrative expenses
1.76%6.37M
12.47%26.91M
23.52%7.29M
25.27%7.1M
-3.14%6.26M
6.21%6.26M
18.13%23.93M
41.00%5.9M
-10.69%5.67M
21.61%6.47M
Research and development costs
17.05%15.78M
35.93%58.19M
53.34%16.82M
20.97%14.03M
24.51%13.85M
47.96%13.48M
26.56%42.8M
28.90%10.97M
35.49%11.6M
30.91%11.13M
Operating profit
-16.67%-22.08M
19.43%-51.81M
140.50%6.75M
-24.30%-20.31M
-14.64%-19.33M
-31.19%-18.92M
-24.84%-64.3M
-33.62%-16.68M
-12.52%-16.34M
-30.13%-16.86M
Net non-operating interest income expense
-594.58%-821K
-134.21%-1.15M
-246.17%-763K
-156.22%-515K
-103.99%-36K
-83.66%166K
-12.81%3.36M
-52.89%522K
0.11%916K
-4.14%902K
Non-operating interest income
----
----
----
----
----
-83.66%166K
-12.81%3.36M
-52.89%522K
0.11%916K
-4.14%902K
Non-operating interest expense
----
--1.15M
----
----
----
----
----
----
----
----
Total other finance cost
594.58%821K
----
----
156.22%515K
103.99%36K
---166K
----
----
---916K
---902K
Other net income (expense)
2.21M
421.52%254K
94.60%-79K
0
25.81%-23K
Gain on sale of security
--2.21M
473.53%254K
----
----
----
----
78.21%-68K
--0
----
25.81%-23K
Special income (charges)
----
----
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
----
----
----
----
----
----
---11K
--0
----
----
Income before tax
-10.32%-20.69M
13.64%-52.7M
138.66%6.25M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
Income tax
Net income
-10.32%-20.69M
13.64%-52.7M
138.66%6.25M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
Net income continuous Operations
-10.32%-20.69M
13.64%-52.7M
138.66%6.25M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
Minority interest income
Net income attributable to the parent company
-10.32%-20.69M
13.64%-52.7M
138.66%6.25M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
Preferred stock dividends
-35K
254K
Other preferred stock dividends
Net income attributable to common stockholders
-10.14%-20.66M
13.22%-52.96M
137.08%5.99M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
Basic earnings per share
32.65%-0.33
33.13%-1.11
160.47%0.26
2.44%-0.4
-11.11%-0.5
-28.95%-0.49
-12.16%-1.66
-16.22%-0.43
-7.89%-0.41
-28.57%-0.45
Diluted earnings per share
32.65%-0.33
33.13%-1.11
160.47%0.26
2.44%-0.4
-11.11%-0.5
-28.95%-0.49
-12.16%-1.66
-16.22%-0.43
-7.89%-0.41
-28.57%-0.45
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -87.33%110K1,169.22%33.48M12,120.16%30.92M-12.77%861K7.46%836K40.00%868K-4.42%2.64M-3.44%253K135.56%987K-14.97%778K
Operating revenue -87.33%110K1,169.22%33.48M12,120.16%30.92M-12.77%861K7.46%836K40.00%868K-4.42%2.64M-3.44%253K135.56%987K-14.97%778K
Cost of revenue -27.27%32K-6.86%190K-12.07%51K-27.94%49K4.55%46K29.41%44K9.68%204K23.40%58K65.85%68K-18.52%44K
Gross profit -90.53%78K1,267.79%33.29M15,728.72%30.87M-11.64%812K7.63%790K40.61%824K-5.44%2.43M-9.30%195K143.12%919K-14.75%734K
Operating expense 12.20%22.15M27.52%85.1M42.91%24.11M22.39%21.13M14.35%20.12M31.55%19.75M23.40%66.74M32.89%16.87M15.83%17.26M27.33%17.59M
Selling and administrative expenses 1.76%6.37M12.47%26.91M23.52%7.29M25.27%7.1M-3.14%6.26M6.21%6.26M18.13%23.93M41.00%5.9M-10.69%5.67M21.61%6.47M
Research and development costs 17.05%15.78M35.93%58.19M53.34%16.82M20.97%14.03M24.51%13.85M47.96%13.48M26.56%42.8M28.90%10.97M35.49%11.6M30.91%11.13M
Operating profit -16.67%-22.08M19.43%-51.81M140.50%6.75M-24.30%-20.31M-14.64%-19.33M-31.19%-18.92M-24.84%-64.3M-33.62%-16.68M-12.52%-16.34M-30.13%-16.86M
Net non-operating interest income expense -594.58%-821K-134.21%-1.15M-246.17%-763K-156.22%-515K-103.99%-36K-83.66%166K-12.81%3.36M-52.89%522K0.11%916K-4.14%902K
Non-operating interest income ---------------------83.66%166K-12.81%3.36M-52.89%522K0.11%916K-4.14%902K
Non-operating interest expense ------1.15M--------------------------------
Total other finance cost 594.58%821K--------156.22%515K103.99%36K---166K-----------916K---902K
Other net income (expense) 2.21M421.52%254K94.60%-79K025.81%-23K
Gain on sale of security --2.21M473.53%254K----------------78.21%-68K--0----25.81%-23K
Special income (charges) --------------------------0------------
Other non- operating income (expenses) ---------------------------11K--0--------
Income before tax -10.32%-20.69M13.64%-52.7M138.66%6.25M-35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M
Income tax
Net income -10.32%-20.69M13.64%-52.7M138.66%6.25M-35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M
Net income continuous Operations -10.32%-20.69M13.64%-52.7M138.66%6.25M-35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M
Minority interest income
Net income attributable to the parent company -10.32%-20.69M13.64%-52.7M138.66%6.25M-35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M
Preferred stock dividends -35K254K
Other preferred stock dividends
Net income attributable to common stockholders -10.14%-20.66M13.22%-52.96M137.08%5.99M-35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M
Basic earnings per share 32.65%-0.3333.13%-1.11160.47%0.262.44%-0.4-11.11%-0.5-28.95%-0.49-12.16%-1.66-16.22%-0.43-7.89%-0.41-28.57%-0.45
Diluted earnings per share 32.65%-0.3333.13%-1.11160.47%0.262.44%-0.4-11.11%-0.5-28.95%-0.49-12.16%-1.66-16.22%-0.43-7.89%-0.41-28.57%-0.45
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.20%
Sample Name
Sample Code
 +14.48%
Sample Name
Sample Code
 +13.51%
4
United States Oil Fund LP
USO
+12.69%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+10.60%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.20%
Sample Name
Sample Code
 +9.95%
Sample Name
Sample Code
 +9.54%
4
Hesai
HSAI
+7.04%
5
NIO Inc
NIO
+6.56%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -